ncRNA name
hsa_circ_0000285
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
Yes
Biomarker application
Prognosis
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Bladder Cancer
Cancer site
Bladder
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Hsa_circ_0000285 expression was lower in cisplatin-resistant bladder cancer patients than in those who were cisplatin-sensitive.
Tissue resource
bladder cancer tissues and adjacent normal tissues
normal bladder epithelial cell lines CCC-HB-2
bladder cancer cell lines HTB-9
bladder cancer cell lines T24
bladder cancer cell lines J82
bladder cancer cell lines SW780
bladder cancer cell lines RT4
Experiment
qRT-PCR
Institute
the First Affiliated Hospital of Jiamusi University
the Chinese Academy of Sciences Cell Bank
Country
China
Continent
Asia